Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
15
×
life sciences
new york blog main
san francisco blog main
boston blog main
boston top stories
national
new york top stories
san francisco top stories
biotech
detroit blog main
detroit top stories
raleigh-durham blog main
san diego blog main
san diego top stories
wisconsin blog main
boulder/denver blog main
boulder/denver top stories
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin top stories
clinical trials
indiana blog main
indiana top stories
fda
cancer
eli lilly
pfizer
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
celgene
ipo
merck
startups
abbvie
What
week
15
×
bio
roundup
life
drug
ipo
science
companies
medicine
moves
big
biogen
ceo
medical
sciences
alzheimer’s
biotech
biotechs
company
conference
debut
firms
group
ipos
march
million
momentum
nasdaq
new
news
open
precision
public
raised
research
rolls
san
street
therapeutics
wall
Language
unset
Current search:
week
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round